PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsCalcitonin salmon
Calcimar, Forcaltonin(calcitonin salmon)
Calcitonin Salmon, Forcaltonin, Fortical, Miacalcin (calcitonin salmon) is a protein pharmaceutical. Calcitonin salmon was first approved as Calcimar on 1982-01-01. It has been approved in Europe to treat bone resorption, hypercalcemia, and osteitis deformans. The pharmaceutical is active against calcitonin receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
musculoskeletal diseasesD009140
nutritional and metabolic diseasesD009750
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
Miacalcin (generic drugs available since 2008-11-17, discontinued: Calcimar, Fortical)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Calcitonin salmon
Tradename
Company
Number
Date
Products
MIACALCINMylanN-017808 RX1991-03-29
1 products, RLD, RS
Show 4 discontinued
Calcitonin salmon recombinant
Tradename
Company
Number
Date
Products
FORTICALUpsher-Smith LaboratoriesN-021406 DISCN2005-08-12
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
calcitonin salmonANDA2024-09-25
calcitonin-salmon2008-11-28
forticalNew Drug Application2010-01-15
miacalcinNew Drug Application2021-08-15
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
H: Systemic hormonal preparations, excl. sex hormones and insulins
— H05: Calcium homeostasis
— H05B: Anti-parathyroid agents
— H05BA: Calcitonin preparations
— H05BA01: Calcitonin (salmon synthetic)
— H05BA02: Calcitonin (pork natural)
— H05BA03: Calcitonin (human synthetic)
N: Nervous system drugs
— N02: Analgesics
— N02C: Antimigraine preparations
— N02CD: Calcitonin gene-related peptide (cgrp) antagonists
HCPCS
Code
Description
J0630
Injection, calcitonin salmon, up to 400 units
Clinical
Clinical Trials
176 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Migraine disordersD008881EFO_0003821G4311613233487
HeadacheD006261HP_0002315R512614922
Bone fracturesD050723EFO_0003931T14.8———123
Myofascial pain syndromesD009209EFO_1001054———11—2
FibromyalgiaD005356EFO_0005687M79.1——11—2
HyperparathyroidismD006961EFO_0008506E21.3———112
AnalgesiaD000698—————1—1
Forearm injuriesD005543—S59.91———1—1
Primary hyperparathyroidismD049950EFO_0008519E21.0———1—1
HypercalcemiaD006934HP_0003072E83.52———1—1
Show 12 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OsteoporosisD010024HP_0000939M81.0226—313
Postmenopausal osteoporosisD015663EFO_0003854—214——7
OsteoarthritisD010003EFO_0002506M15-M19212——5
Knee osteoarthritisD020370EFO_0004616M17——2——2
PostmenopauseD017698————1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Thyroid neoplasmsD013964EFO_0003841—24——39
Thyroid diseasesD013959HP_0000820E00-E0724——39
Papillary thyroid cancerD000077273——21——36
Brain concussionD001924—S06.0—2——24
Post-traumatic headacheD051298—G44.3—3——14
CarcinomaD002277—C80.0—2——24
Neuroendocrine carcinomaD018278———1——34
NeuralgiaD009437EFO_0009430——2——13
Traumatic brain injuriesD000070642—S06—2———2
Brain injuriesD001930—S06.9—2———2
Show 27 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———7———18
NeoplasmsD009369—C801———12
Neuroendocrine tumorsD018358EFO_1001901D3A.81———12
Coronary diseaseD003327——1———12
Heart diseasesD006331EFO_0003777I51.91———12
Coronary artery diseaseD003324—I25.11————1
Myocardial ischemiaD017202EFO_1001375I20-I251————1
Lung neoplasmsD008175HP_0100526C34.901————1
Hot flashesD019584——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Migraine with auraD020325EFO_0005295G43.1————55
Migraine without auraD020326EFO_0005296G43.0————44
HypophosphatemiaD017674HP_0002148—————22
Endocrine gland neoplasmsD004701EFO_0003769D35————11
Islet cell adenomaD007516EFO_0007331D13.7————11
Multiple endocrine neoplasiaD009377—E31.2————11
Diabetes mellitusD003920HP_0000819E08-E13————11
Diabetes insipidusD003919—E23.2————11
Nephrogenic diabetes insipidusD018500—N25.1————11
Ulnar neuropathiesD020424EFO_1001224—————11
Show 46 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCalcitonin salmon
INN—
Description
Forcaltonin, Fortical, Miacalcin (calcitonin salmon) is a protein pharmaceutical. Calcitonin salmon was first approved as Calcimar on 1982-01-01. It has been approved in Europe to treat bone resorption, hypercalcemia, and osteitis deformans. The pharmaceutical is active against calcitonin receptor.
Classification
Protein
Drug classvitamin D analogs; anti-inflammatory agents (salicylic acid derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
Identifiers
PDB—
CAS-ID9007-12-9
RxCUI—
ChEMBL IDCHEMBL3989767
ChEBI ID—
PubChem CID—
DrugBankDB00017
UNII ID—
Target
Agency Approved
CALCR
CALCR
Organism
Homo sapiens
Gene name
CALCR
Gene synonyms
NCBI Gene ID
799
Protein name
calcitonin receptor
Protein synonyms
Uniprot ID
Q6T712
Mouse ortholog
Calcr (12311)
calcitonin receptor (Q8CAB0)
Alternate
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 220 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1,459 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use